Correlation Between Nomura Holdings and Dianthus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nomura Holdings and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nomura Holdings and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nomura Holdings ADR and Dianthus Therapeutics, you can compare the effects of market volatilities on Nomura Holdings and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nomura Holdings with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nomura Holdings and Dianthus Therapeutics.
Diversification Opportunities for Nomura Holdings and Dianthus Therapeutics
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Nomura and Dianthus is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Nomura Holdings ADR and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Nomura Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nomura Holdings ADR are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Nomura Holdings i.e., Nomura Holdings and Dianthus Therapeutics go up and down completely randomly.
Pair Corralation between Nomura Holdings and Dianthus Therapeutics
Considering the 90-day investment horizon Nomura Holdings is expected to generate 24.51 times less return on investment than Dianthus Therapeutics. But when comparing it to its historical volatility, Nomura Holdings ADR is 24.13 times less risky than Dianthus Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 84.00 in Dianthus Therapeutics on October 1, 2024 and sell it today you would earn a total of 2,190 from holding Dianthus Therapeutics or generate 2607.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Nomura Holdings ADR vs. Dianthus Therapeutics
Performance |
Timeline |
Nomura Holdings ADR |
Dianthus Therapeutics |
Nomura Holdings and Dianthus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nomura Holdings and Dianthus Therapeutics
The main advantage of trading using opposite Nomura Holdings and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nomura Holdings position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.Nomura Holdings vs. Perella Weinberg Partners | Nomura Holdings vs. Oppenheimer Holdings | Nomura Holdings vs. Stifel Financial Corp | Nomura Holdings vs. Piper Sandler Companies |
Dianthus Therapeutics vs. EMCOR Group | Dianthus Therapeutics vs. Everus Construction Group | Dianthus Therapeutics vs. Origin Materials | Dianthus Therapeutics vs. ReTo Eco Solutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data |